Structure

Physi-Chem Properties

Molecular Weight:  370.14
Volume:  371.832
LogP:  3.059
LogD:  2.947
LogS:  -4.526
# Rotatable Bonds:  5
TPSA:  63.22
# H-Bond Aceptor:  6
# H-Bond Donor:  0
# Rings:  4
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.737
Synthetic Accessibility Score:  4.347
Fsp3:  0.381
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.658
MDCK Permeability:  1.6834865164128132e-05
Pgp-inhibitor:  0.988
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.935
30% Bioavailability (F30%):  0.941

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.066
Plasma Protein Binding (PPB):  87.7139663696289%
Volume Distribution (VD):  1.18
Pgp-substrate:  7.085323333740234%

ADMET: Metabolism

CYP1A2-inhibitor:  0.81
CYP1A2-substrate:  0.959
CYP2C19-inhibitor:  0.938
CYP2C19-substrate:  0.821
CYP2C9-inhibitor:  0.788
CYP2C9-substrate:  0.616
CYP2D6-inhibitor:  0.956
CYP2D6-substrate:  0.146
CYP3A4-inhibitor:  0.971
CYP3A4-substrate:  0.799

ADMET: Excretion

Clearance (CL):  10.083
Half-life (T1/2):  0.313

ADMET: Toxicity

hERG Blockers:  0.053
Human Hepatotoxicity (H-HT):  0.815
Drug-inuced Liver Injury (DILI):  0.069
AMES Toxicity:  0.033
Rat Oral Acute Toxicity:  0.412
Maximum Recommended Daily Dose:  0.765
Skin Sensitization:  0.8
Carcinogencity:  0.871
Eye Corrosion:  0.007
Eye Irritation:  0.028
Respiratory Toxicity:  0.969

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC50696

Natural Product ID:  NPC50696
Common Name*:   (2R,3S,3As)-5-Methoxy-2-(7-Methoxy-1,3-Benzodioxol-5-Yl)-3-Methyl-3A-Prop-2-Enyl-2,3-Dihydro-1-Benzofuran-6-One
IUPAC Name:   (2R,3S,3aS)-5-methoxy-2-(7-methoxy-1,3-benzodioxol-5-yl)-3-methyl-3a-prop-2-enyl-2,3-dihydro-1-benzofuran-6-one
Synonyms:  
Standard InCHIKey:  URBCBHTUEUNACZ-PCFDJQJPSA-N
Standard InCHI:  InChI=1S/C21H22O6/c1-5-6-21-10-17(24-4)14(22)9-18(21)27-19(12(21)2)13-7-15(23-3)20-16(8-13)25-11-26-20/h5,7-10,12,19H,1,6,11H2,2-4H3/t12-,19-,21-/m1/s1
SMILES:  C=CC[C@@]12C=C(C(=O)C=C2O[C@H]([C@H]1C)c1cc(c2c(c1)OCO2)OC)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL524122
PubChem CID:   44576119
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003405] 2-arylbenzofuran flavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO14069 Endlicheria dysodantha Species Lauraceae Eukaryota n.a. n.a. n.a. PMID[1665173]
NPO14069 Endlicheria dysodantha Species Lauraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell Line A549 Homo sapiens ED50 > 100.0 ug ml-1 PMID[491163]
NPT83 Cell Line MCF7 Homo sapiens ED50 = 79.0 ug ml-1 PMID[491163]
NPT139 Cell Line HT-29 Homo sapiens ED50 = 96.5 ug ml-1 PMID[491163]
NPT140 Organism Artemia Artemia LC50 = 162.1 ppm PMID[491163]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC50696 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9706 High Similarity NPC278076
0.9441 High Similarity NPC475170
0.9231 High Similarity NPC25496
0.9137 High Similarity NPC166184
0.9122 High Similarity NPC117154
0.9071 High Similarity NPC178290
0.8986 High Similarity NPC136750
0.8986 High Similarity NPC266848
0.8951 High Similarity NPC474966
0.8921 High Similarity NPC145769
0.8913 High Similarity NPC72046
0.8913 High Similarity NPC65183
0.8913 High Similarity NPC261812
0.8857 High Similarity NPC189474
0.8841 High Similarity NPC192255
0.8828 High Similarity NPC476841
0.8828 High Similarity NPC476843
0.8794 High Similarity NPC11453
0.8786 High Similarity NPC31530
0.8759 High Similarity NPC15743
0.8723 High Similarity NPC49235
0.8723 High Similarity NPC25333
0.8723 High Similarity NPC148893
0.8662 High Similarity NPC143895
0.8662 High Similarity NPC121651
0.8643 High Similarity NPC7744
0.8633 High Similarity NPC339621
0.8633 High Similarity NPC280399
0.8633 High Similarity NPC233961
0.8623 High Similarity NPC165128
0.8623 High Similarity NPC82862
0.8623 High Similarity NPC158471
0.8623 High Similarity NPC222127
0.8623 High Similarity NPC226862
0.8623 High Similarity NPC57119
0.8621 High Similarity NPC46180
0.8621 High Similarity NPC476840
0.8621 High Similarity NPC476842
0.8621 High Similarity NPC287124
0.8601 High Similarity NPC185908
0.8591 High Similarity NPC85141
0.8571 High Similarity NPC227160
0.8571 High Similarity NPC82111
0.8552 High Similarity NPC51681
0.8552 High Similarity NPC312199
0.8551 High Similarity NPC473092
0.8551 High Similarity NPC8050
0.8551 High Similarity NPC473093
0.8544 High Similarity NPC474948
0.8544 High Similarity NPC42230
0.8542 High Similarity NPC113550
0.8533 High Similarity NPC177830
0.8514 High Similarity NPC472560
0.8503 High Similarity NPC141569
0.8503 High Similarity NPC475000
0.8503 High Similarity NPC166884
0.8503 High Similarity NPC477701
0.85 High Similarity NPC233224
0.85 High Similarity NPC271208
0.8497 Intermediate Similarity NPC476363
0.8493 Intermediate Similarity NPC80326
0.8493 Intermediate Similarity NPC210354
0.8493 Intermediate Similarity NPC176586
0.8493 Intermediate Similarity NPC472562
0.8489 Intermediate Similarity NPC54321
0.8489 Intermediate Similarity NPC328682
0.8489 Intermediate Similarity NPC281864
0.8483 Intermediate Similarity NPC216434
0.8483 Intermediate Similarity NPC46591
0.8483 Intermediate Similarity NPC103448
0.8483 Intermediate Similarity NPC177868
0.8478 Intermediate Similarity NPC50683
0.8478 Intermediate Similarity NPC285725
0.8478 Intermediate Similarity NPC112571
0.8477 Intermediate Similarity NPC163002
0.8472 Intermediate Similarity NPC283949
0.8467 Intermediate Similarity NPC472567
0.8462 Intermediate Similarity NPC150534
0.8462 Intermediate Similarity NPC174191
0.8451 Intermediate Similarity NPC196937
0.8451 Intermediate Similarity NPC1474
0.8447 Intermediate Similarity NPC474568
0.8446 Intermediate Similarity NPC477702
0.8446 Intermediate Similarity NPC474158
0.8435 Intermediate Similarity NPC255566
0.8435 Intermediate Similarity NPC298317
0.8425 Intermediate Similarity NPC58137
0.8425 Intermediate Similarity NPC300798
0.8418 Intermediate Similarity NPC475953
0.8417 Intermediate Similarity NPC64948
0.84 Intermediate Similarity NPC198129
0.84 Intermediate Similarity NPC327352
0.84 Intermediate Similarity NPC477375
0.84 Intermediate Similarity NPC252281
0.8389 Intermediate Similarity NPC212890
0.8389 Intermediate Similarity NPC193779
0.838 Intermediate Similarity NPC171928
0.838 Intermediate Similarity NPC129687
0.838 Intermediate Similarity NPC33611
0.838 Intermediate Similarity NPC158526
0.838 Intermediate Similarity NPC100223
0.838 Intermediate Similarity NPC16830
0.8378 Intermediate Similarity NPC191158
0.8378 Intermediate Similarity NPC177644
0.8367 Intermediate Similarity NPC151423
0.8367 Intermediate Similarity NPC474295
0.8367 Intermediate Similarity NPC174522
0.8367 Intermediate Similarity NPC40237
0.8367 Intermediate Similarity NPC311057
0.8356 Intermediate Similarity NPC226547
0.8356 Intermediate Similarity NPC56091
0.8345 Intermediate Similarity NPC88297
0.8345 Intermediate Similarity NPC186845
0.8345 Intermediate Similarity NPC9891
0.8344 Intermediate Similarity NPC322426
0.8344 Intermediate Similarity NPC477376
0.8344 Intermediate Similarity NPC477374
0.8333 Intermediate Similarity NPC121783
0.8333 Intermediate Similarity NPC474139
0.8333 Intermediate Similarity NPC18449
0.8333 Intermediate Similarity NPC34902
0.8322 Intermediate Similarity NPC180953
0.8312 Intermediate Similarity NPC178195
0.8312 Intermediate Similarity NPC348849
0.8312 Intermediate Similarity NPC198461
0.8312 Intermediate Similarity NPC312763
0.8311 Intermediate Similarity NPC185071
0.8311 Intermediate Similarity NPC474808
0.8311 Intermediate Similarity NPC12728
0.8311 Intermediate Similarity NPC76415
0.8311 Intermediate Similarity NPC218510
0.8311 Intermediate Similarity NPC474288
0.8302 Intermediate Similarity NPC474647
0.8301 Intermediate Similarity NPC475229
0.8301 Intermediate Similarity NPC477378
0.8298 Intermediate Similarity NPC476748
0.8289 Intermediate Similarity NPC316989
0.8278 Intermediate Similarity NPC262804
0.8278 Intermediate Similarity NPC40654
0.8276 Intermediate Similarity NPC32189
0.8273 Intermediate Similarity NPC85830
0.8264 Intermediate Similarity NPC170779
0.8264 Intermediate Similarity NPC37065
0.8264 Intermediate Similarity NPC47181
0.8264 Intermediate Similarity NPC90083
0.8255 Intermediate Similarity NPC218841
0.8255 Intermediate Similarity NPC326144
0.8255 Intermediate Similarity NPC92693
0.8252 Intermediate Similarity NPC147616
0.8252 Intermediate Similarity NPC259742
0.8252 Intermediate Similarity NPC219671
0.8252 Intermediate Similarity NPC104077
0.825 Intermediate Similarity NPC476277
0.8247 Intermediate Similarity NPC477377
0.8219 Intermediate Similarity NPC474039
0.8219 Intermediate Similarity NPC20796
0.8219 Intermediate Similarity NPC196420
0.8207 Intermediate Similarity NPC18576
0.8207 Intermediate Similarity NPC236522
0.8207 Intermediate Similarity NPC135777
0.8207 Intermediate Similarity NPC99572
0.8207 Intermediate Similarity NPC126409
0.8207 Intermediate Similarity NPC142547
0.82 Intermediate Similarity NPC205316
0.82 Intermediate Similarity NPC327651
0.82 Intermediate Similarity NPC318286
0.8188 Intermediate Similarity NPC288238
0.8182 Intermediate Similarity NPC56184
0.817 Intermediate Similarity NPC12854
0.817 Intermediate Similarity NPC473989
0.8163 Intermediate Similarity NPC88640
0.8163 Intermediate Similarity NPC123526
0.8163 Intermediate Similarity NPC9068
0.8163 Intermediate Similarity NPC193666
0.8162 Intermediate Similarity NPC119949
0.8156 Intermediate Similarity NPC158737
0.8151 Intermediate Similarity NPC209229
0.8151 Intermediate Similarity NPC78047
0.8151 Intermediate Similarity NPC25695
0.8151 Intermediate Similarity NPC172818
0.8146 Intermediate Similarity NPC321696
0.8146 Intermediate Similarity NPC321958
0.8141 Intermediate Similarity NPC188962
0.8141 Intermediate Similarity NPC202249
0.8141 Intermediate Similarity NPC42871
0.8138 Intermediate Similarity NPC145722
0.8138 Intermediate Similarity NPC185680
0.8138 Intermediate Similarity NPC256776
0.8133 Intermediate Similarity NPC239254
0.8133 Intermediate Similarity NPC297342
0.8133 Intermediate Similarity NPC172171
0.8129 Intermediate Similarity NPC297271
0.8129 Intermediate Similarity NPC53669
0.8129 Intermediate Similarity NPC77237
0.8129 Intermediate Similarity NPC16791
0.8129 Intermediate Similarity NPC126405
0.8129 Intermediate Similarity NPC24562
0.8129 Intermediate Similarity NPC308555
0.8129 Intermediate Similarity NPC308739
0.8129 Intermediate Similarity NPC217708

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC50696 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8116 Intermediate Similarity NPD3705 Approved
0.7922 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7862 Intermediate Similarity NPD4966 Approved
0.7862 Intermediate Similarity NPD4965 Approved
0.7862 Intermediate Similarity NPD4967 Phase 2
0.7764 Intermediate Similarity NPD6234 Discontinued
0.7683 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7673 Intermediate Similarity NPD37 Approved
0.7671 Intermediate Similarity NPD3027 Phase 3
0.7532 Intermediate Similarity NPD1653 Approved
0.7518 Intermediate Similarity NPD1357 Approved
0.75 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD5494 Approved
0.7464 Intermediate Similarity NPD5283 Phase 1
0.7455 Intermediate Similarity NPD7199 Phase 2
0.744 Intermediate Similarity NPD3818 Discontinued
0.744 Intermediate Similarity NPD7228 Approved
0.7438 Intermediate Similarity NPD7028 Phase 2
0.7423 Intermediate Similarity NPD3882 Suspended
0.7376 Intermediate Similarity NPD5536 Phase 2
0.7362 Intermediate Similarity NPD3817 Phase 2
0.7333 Intermediate Similarity NPD919 Approved
0.731 Intermediate Similarity NPD2981 Phase 2
0.7299 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD7240 Approved
0.726 Intermediate Similarity NPD2983 Phase 2
0.726 Intermediate Similarity NPD2982 Phase 2
0.7246 Intermediate Similarity NPD1247 Approved
0.7226 Intermediate Similarity NPD7266 Discontinued
0.7225 Intermediate Similarity NPD7808 Phase 3
0.7222 Intermediate Similarity NPD6599 Discontinued
0.7209 Intermediate Similarity NPD6797 Phase 2
0.7181 Intermediate Similarity NPD3018 Phase 2
0.7178 Intermediate Similarity NPD5089 Approved
0.7178 Intermediate Similarity NPD5090 Approved
0.7171 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7171 Intermediate Similarity NPD1613 Approved
0.7168 Intermediate Similarity NPD7251 Discontinued
0.716 Intermediate Similarity NPD3926 Phase 2
0.7152 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD7074 Phase 3
0.7143 Intermediate Similarity NPD6111 Discontinued
0.7134 Intermediate Similarity NPD1934 Approved
0.7126 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD7124 Phase 2
0.7093 Intermediate Similarity NPD7054 Approved
0.7091 Intermediate Similarity NPD4585 Approved
0.7089 Intermediate Similarity NPD4110 Phase 3
0.7089 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD7314 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD5297 Approved
0.7063 Intermediate Similarity NPD6799 Approved
0.7052 Intermediate Similarity NPD7472 Approved
0.7048 Intermediate Similarity NPD5353 Approved
0.7029 Intermediate Similarity NPD1358 Approved
0.7027 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD6674 Discontinued
0.702 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7018 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7018 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7018 Intermediate Similarity NPD6166 Phase 2
0.7006 Intermediate Similarity NPD1375 Discontinued
0.7 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.6988 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6988 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6981 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6974 Remote Similarity NPD7095 Approved
0.6971 Remote Similarity NPD6559 Discontinued
0.6968 Remote Similarity NPD2492 Phase 1
0.6964 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6959 Remote Similarity NPD5242 Approved
0.6957 Remote Similarity NPD4357 Discontinued
0.6957 Remote Similarity NPD3134 Approved
0.6954 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6951 Remote Similarity NPD6055 Clinical (unspecified phase)
0.6949 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6948 Remote Similarity NPD4060 Phase 1
0.6943 Remote Similarity NPD2796 Approved
0.6941 Remote Similarity NPD8127 Discontinued
0.6936 Remote Similarity NPD3751 Discontinued
0.6928 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6927 Remote Similarity NPD6841 Approved
0.6927 Remote Similarity NPD6843 Phase 3
0.6927 Remote Similarity NPD6842 Approved
0.6918 Remote Similarity NPD5691 Approved
0.6908 Remote Similarity NPD4908 Phase 1
0.6905 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6903 Remote Similarity NPD3657 Discovery
0.6903 Remote Similarity NPD6355 Discontinued
0.6899 Remote Similarity NPD5763 Approved
0.6899 Remote Similarity NPD5762 Approved
0.6897 Remote Similarity NPD5844 Phase 1
0.6897 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6892 Remote Similarity NPD1091 Approved
0.689 Remote Similarity NPD4210 Discontinued
0.6886 Remote Similarity NPD2801 Approved
0.6879 Remote Similarity NPD3748 Approved
0.6875 Remote Similarity NPD7157 Approved
0.6875 Remote Similarity NPD4628 Phase 3
0.6871 Remote Similarity NPD1940 Clinical (unspecified phase)
0.6864 Remote Similarity NPD7075 Discontinued
0.6864 Remote Similarity NPD7975 Clinical (unspecified phase)
0.6845 Remote Similarity NPD5402 Approved
0.6839 Remote Similarity NPD3619 Clinical (unspecified phase)
0.6839 Remote Similarity NPD3620 Phase 2
0.6832 Remote Similarity NPD5084 Clinical (unspecified phase)
0.6832 Remote Similarity NPD6190 Approved
0.6826 Remote Similarity NPD3382 Approved
0.6826 Remote Similarity NPD3383 Approved
0.6826 Remote Similarity NPD3384 Approved
0.6826 Remote Similarity NPD6801 Discontinued
0.6821 Remote Similarity NPD1049 Clinical (unspecified phase)
0.6818 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6813 Remote Similarity NPD1652 Phase 2
0.6803 Remote Similarity NPD5585 Approved
0.6802 Remote Similarity NPD3787 Discontinued
0.68 Remote Similarity NPD4749 Approved
0.68 Remote Similarity NPD5327 Phase 3
0.6795 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6795 Remote Similarity NPD230 Phase 1
0.6795 Remote Similarity NPD5124 Phase 1
0.6782 Remote Similarity NPD7473 Discontinued
0.678 Remote Similarity NPD7685 Pre-registration
0.6779 Remote Similarity NPD1610 Phase 2
0.6779 Remote Similarity NPD422 Phase 1
0.6768 Remote Similarity NPD1512 Approved
0.6755 Remote Similarity NPD8651 Approved
0.6755 Remote Similarity NPD5005 Approved
0.6755 Remote Similarity NPD5006 Approved
0.6746 Remote Similarity NPD6374 Clinical (unspecified phase)
0.6742 Remote Similarity NPD7549 Discontinued
0.6736 Remote Similarity NPD1241 Discontinued
0.6732 Remote Similarity NPD2861 Phase 2
0.6731 Remote Similarity NPD4140 Approved
0.673 Remote Similarity NPD3539 Phase 1
0.6727 Remote Similarity NPD5403 Approved
0.6724 Remote Similarity NPD4481 Phase 3
0.6724 Remote Similarity NPD2403 Approved
0.6723 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6713 Remote Similarity NPD228 Approved
0.6711 Remote Similarity NPD3496 Discontinued
0.671 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6708 Remote Similarity NPD4236 Phase 3
0.6708 Remote Similarity NPD4237 Approved
0.6707 Remote Similarity NPD3688 Clinical (unspecified phase)
0.6707 Remote Similarity NPD5401 Approved
0.6707 Remote Similarity NPD3146 Approved
0.6707 Remote Similarity NPD4380 Phase 2
0.6707 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6705 Remote Similarity NPD6232 Discontinued
0.6688 Remote Similarity NPD1933 Approved
0.6688 Remote Similarity NPD5735 Approved
0.6688 Remote Similarity NPD4340 Discontinued
0.6687 Remote Similarity NPD5058 Phase 3
0.6687 Remote Similarity NPD6783 Clinical (unspecified phase)
0.6687 Remote Similarity NPD3540 Phase 1
0.6686 Remote Similarity NPD5563 Clinical (unspecified phase)
0.6686 Remote Similarity NPD7819 Suspended
0.6684 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6667 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6667 Remote Similarity NPD3750 Approved
0.6667 Remote Similarity NPD6385 Approved
0.6667 Remote Similarity NPD6233 Phase 2
0.6667 Remote Similarity NPD8166 Discontinued
0.6667 Remote Similarity NPD6386 Approved
0.6647 Remote Similarity NPD2560 Approved
0.6647 Remote Similarity NPD2563 Approved
0.6647 Remote Similarity NPD7458 Discontinued
0.6646 Remote Similarity NPD1511 Approved
0.6646 Remote Similarity NPD970 Clinical (unspecified phase)
0.6646 Remote Similarity NPD2424 Discontinued
0.6644 Remote Similarity NPD4626 Approved
0.6632 Remote Similarity NPD7680 Approved
0.6631 Remote Similarity NPD4420 Approved
0.663 Remote Similarity NPD7296 Approved
0.6628 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6627 Remote Similarity NPD920 Approved
0.6626 Remote Similarity NPD2219 Phase 1
0.6625 Remote Similarity NPD6100 Approved
0.6625 Remote Similarity NPD6099 Approved
0.6625 Remote Similarity NPD2438 Suspended
0.6625 Remote Similarity NPD2161 Phase 2
0.6623 Remote Similarity NPD3972 Approved
0.662 Remote Similarity NPD2684 Approved
0.6608 Remote Similarity NPD5019 Clinical (unspecified phase)
0.6606 Remote Similarity NPD2532 Approved
0.6606 Remote Similarity NPD2533 Approved
0.6606 Remote Similarity NPD2534 Approved
0.6605 Remote Similarity NPD2800 Approved
0.6604 Remote Similarity NPD6896 Approved
0.6604 Remote Similarity NPD6895 Approved
0.6603 Remote Similarity NPD5111 Phase 2
0.6603 Remote Similarity NPD6798 Discontinued
0.6603 Remote Similarity NPD5109 Approved
0.6603 Remote Similarity NPD5110 Phase 2
0.6597 Remote Similarity NPD969 Suspended
0.6593 Remote Similarity NPD8434 Phase 2
0.6588 Remote Similarity NPD2977 Approved
0.6588 Remote Similarity NPD2978 Approved
0.6587 Remote Similarity NPD3686 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data